NCT07473154: Controlling Hyperactive Immunity With Long-lived Lymphocytes
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 16 planned
- Started
- 10 Apr 2026
- Primary completion
- Aug 2028
- Arms
- Dose Escalation, Dose Expansion
- Results
- None posted
- 16 Mar 2026: Trial registered
- 10 Apr 2026: Trial started